T1	Participants 298 460	Long-term followup was assessed in 551 participants enrolled in a prospective, randomized study of fluorescence cystoscopy for Ta or T1 urothelial bladder cancer.
T2	Participants 483 531	280 patients in the white light cystoscopy group
T3	Participants 536 606	271 in the fluorescence cystoscopy group were followed with cystoscopy
T4	Participants 769 852	information was obtained for 261 of the 280 patients (93%) in the white light group
T5	Participants 857 904	255 of the 271 (94%) in the fluorescence group.
